Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women

• Status: Completed
• Trial end date: 2010-09-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to determine whether bazedoxifene acetate is safe and effective in the treatment of osteoporosis in postmenopausal women.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer
• Treatments: Bazedoxifene

Criteria

Inclusion Criteria:

• Must be at least 2 years postmenopausal

• Osteoporotic subjects without vertebral fracture who meet BMD criteria, or Osteoporotic subjects with vertebral fracture

Exclusion Criteria:

• Diseases that may affect bone metabolism

• Vasomotor symptoms requiring treatment

• Known history or suspected cancer of the breast

• Active or past history of venous thromboembolic events